Clinical significance of abdominal obesity;Significado clínico de la obesidad abdominal

Endocrinologia y Nutricion

Volumn 54, Issue 5, 2007, Pages 265-271

  Velasco, Pedro Luis De Pablos ^a   Martín, Francisco Javier Martínez ^a  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Cardiometabolic risk; Central obesity; Diabetes mellitus; Dyslipemia

Indexed keywords

ADIPOCYTOKINE; FATTY ACID; INSULIN RECEPTOR SUBSTRATE 1; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL OBESITY; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; DYSLIPIDEMIA; EUROPE; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; REVIEW; UNITED STATES;

EID: 34347388681     PISSN: 15750922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1575-0922(07)71446-8     Document Type: Review

References (62)

1. G Bray. Contemporary diagnosis and management of obesity. Pennsylvania: Handbooks in Healthcare Co; 1998.
2. Strain GW, Zumoff B. The relationship of weight-height indices of obesity to body fat content. J Am Coll Nutr. 1992;11: 715-8.
3. Frankenfield DC, Rowe WA, Cooney RN, Smith JS, Becker D. Limits of body mass index to detect obesity and predict body composition. Nutrition. 2001;17:26-30.
4. Welborn TA, Knuiman MW, Vu HT. Body mass index and alternative indices of obesity in relation to height, triceps skinfold and subsequent mortality: the Busselton health study. Int J Obes Relat Metab Disord. 2000;24:108-15.
5. Wells JC, Coward WA, Cole TJ. Davies PS. The contribution of fat and fat-free tissue to body mass index in contemporary children and the reference child. Int J Obes Relat Metab Disord. 2002;26:1323-8.
6. National Institutes of Health. National Heart, Lung and Blood Institute. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. The evidence report. Bethesda, June 1999.
7. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagital diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460-8.
8. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord. 2004;28:1018-25.
9. Stolk RP, Wink O, Zelissen PM, Meijer R, Van Gils AP, Grobbee DE. Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord. 2001;25:1346-51.
10. Stolk RP, Meijer R, Mali WP, Grobbee DE, Van der Graaf Y. Secondary manifestations of arterial disease study group. Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. Am J Clin Nutr. 2003;77:857-60.
11. Concepción L, Martí-Bonmatí L, Aliaga R, Delgado F, Morillas C, Hernández A. Estudio de la grasa abdominal mediante resonancia magnética: comparación con parámetros antropométricos y de riesgo cardiovascular. Med Clin (Bare). 2001;117:366-9.
12. Despres JP, Lamarche B. Low-intensity endurance exercise trainning, plasma lipoproteins and the risk of coronary heart disease. J Intern Med. 1994;236:7-22.
13. Examination Committee of Criteria for Obesity Disease in Japan. New criteria for obesity disease in Japan. Circ J. 2002;66:987-92.
14. Han TS, McNeill G, Seidell JC, Lean ME. Predicting intra-abdominal fatness from anthropometric measures: the influence of stature. Int J Obes Relat Metab Disord. 1997;21:587-93.
15. Rankinen T, Kim SY, Perusse L, Despres JP, Bouchard C. The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis. Int J Obes Relat Metab Disord. 1999;23:801-9.
16. Snell-Bergeon JK, Hokanson JE, Kinney GL, Dabelea D, Ehrlich J, Eckel RH, et al. Measurement of abdominal fat by CT compared to waist circumference and BMI in explaining the presence of coronary calcium. Int J Obes Relat Metab Disord. 2004;28:1594-9.
17. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneve: WHO; 1998.
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP), Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
19. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group.The metabolic syndrome a new worldwide definition Lancet. 2005;366:1059-62.
20. Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among US adults. Obes Res. 2003;11:1223-31.
21. Alvárez León EE, Ribas Barba L, Serra Majem L. Prevalencia del síndrome metabólico en la población de la Comunidad Canaria. Med Clin (Barc). 2003;120:172-4.
22. Visscher TL, Seidell JC. Time trends (1993-1997) and seasonal variation in body mass index and waist circumference in the Netherlands. Int J Obes Relat Metab Disord. 2004;28:1309-16.
23. Liese AD, Doring A, Hense HW, Keil U. Five year changes in waist circumference, body mass index and obesity in Augsburg, Germany. Eur J Nutr. 2001;40:282-8.
24. James PT, Rigby N, Leach R. International Obesity Task Force. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil. 2004;11:3-8.
25. Balkau B, Vernay M, Mhamdi L, Novak M, Arondel D, Vol S, et al; DESIR Study Group. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French DESIR study. Diabetes Metab. 2003;29: 526-32.
26. Scheen AJ. From obesity to diabetes: why, when and who? Acta Clin Belg. 2000;55:9-15.
27. Zimmet PZ. Challenges in diabetes. Epidemiology from West to the rest. Diabetes Care. 1991;15:232-52.
28. Ravussin E. Energy metabolism in obesity studies in the Pima Indians. Diabetes Care. 1993;16:232-8.
29. Bjorntorp P. Abdominal obesity and the metabolic syndrome. Ann Med. 1994;24:465-8.
30. Larsson B. Obesity and prospective risk of associated diseases. En: Vague J, Bjorntorp P, Guy-Grand B, RebuffeScrive M, Vague P, editores. Metabolic Complications of the Human Obesities. Amsterdam: Elsevier; 1985. p. 21-9.
31. Chan JM, Stampfer MJ, Rimm EB, Willett WC, Colditz GA. Obesity, fat distribution and weight gains as risk factors for clinical diabetes in man. Diabetes Care. 1994;17:961-9.
32. De Pablos-Velasco PL, Martínez-Martín FJ, Rodríguez-Pérez F. Prevalence of obesity in a Canarian community. Association with type 2 diabetes mellitus: the Guia Study. Eur J Clin Nutr. 2002;56:557-60.
33. De Pablos-Velasco PL, Martínez-Martín FJ, Rodríguez-Pérez F, Ania BJ, Losada A, Betancor P. Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population -comparison of the 1997 ADA and the 1985 WHO criteria. The Guia Study. Diabet Med. 2001;18: 235-41.
34. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990;10: 497-511.
35. Tchernof A, Lamarche B, Prud'Homme D, Nadeau A, Moorjani S, Labrie F, et al. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care. 1996;19:629-37.
36. Large V, Amer P. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab. 1998;24:409-18.
37. Amer P, Bolinder J, Engfeldt P, Hellrner J, Ostman J. Influence of obesity on the antilipolytic effect of insulin in isolated human fat cells obtained before and after glucose ingestion. J Clin Invest. 1984;73:673-80.
38. Taylor R. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism. 1996;45:947-50.
39. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J. 1999;13:2051-60.
40. Gibbons GF, Islam K, Pease RJ. Mobilization of triacylglycerol stores. Biochem Biophys Acta. 2000;1483:37-57.
41. Lonnqvist F, Thorne A, Nilsell K, Hoffstedt J, Arner P. A pathogenetic role of visceral α-adrenoreceptors in obesity. Clin Invest. 1995;95:1109-16.
42. Rosell R, Belfrage E. Blood circulation in adipose tissue. Physiol Rev. 1979;59:1078-104.
43. Campra JL, Reynolds TB The hepatic circulation. En: Arias IM, Popper H, Schachter D, Shafritz DA, editores. The liver: biology and pathobiology. New York: Raven Press; 1982. p. 627-45.
44. Misra A, Garg A, Abate N, Peshock RM, Stray-Gundersen J, Grundy SM. Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obes Res. 1997;5:93-9.
45. Hotamisigil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor in human obesity and insulin resistance. J Clin Invest. 1995;95:2409-15.
46. Flier JS. The missing link with obesity? Nature. 2001;409;307-12.
47. Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, Orlova C, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab. 2003;88:4823-31.
48. Ohashi K, Ouchi N, Kihara S, Funahashi T, Nakamura T, Sumitsuji S, et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol. 2004;43:1195-200.
49. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem. 2003;278:40352-63.
50. Rebuffe-Scrive M, Anderson B, Olbe L, Bjorntorp P. Metabolism of adipose tissue in intraabdominal depots in severely obese men and women. Metabolism. 1990;39:1021-5.
51. Large V, Arner P. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab. 1998;24:409-18.
52. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev. 2002;23:201-29.
53. Peiris AN, Mueller RA, Smith GA, Struve MF, Kissebah AH. Splanchnic insulin metabolism in obesity: Influence of body fat distribution. J Clin Invest. 1986;78:1648-57.
54. Peiris AN, Struve MF, Mueller RA, Lee MB, Kissebah AH. Glucose metabolism in obesity: influence of body fat distribution. J Clin Endocrinol Metab. 1988;67:760-7.
55. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999;341:1097-105.
56. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body weight and mortality among women. N Engl J Med. 1995;333:677-85.
57. Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA. 1999;282:1530-8.
58. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867-72.
59. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003;138:24-32.
60. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998;280:1843-8.
61. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-52.
62. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366: 1640-9.